[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349554-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349554-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-brca1-and-brca2-germline-mutations-in-female-breast-cancer-patients-using-next-generation-sequencing","Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing","","Breast cancer is the most common cancer in females, and BRCA1/BRCA2 are major tumor suppressor genes linked to susceptibility. This study investigates germline mutations in Egyptian female breast cancer patients using next-generation sequencing. Blood samples from primary breast cancer patients (n=22), benign breast lesions (n=5), and healthy controls (n=7) were analyzed. Results identified 135 variations across BRCA1 and BRCA2, including 13 novel BRCA2 mutations and predominantly missense and intronic changes. Germline profiling revealed 135 variations overall, suggesting clinical benefit from refined mutational analysis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-brca1-and-brca2-germline-mutations-in-female-breast-cancer-patients-using-next-generation-sequencing/349554/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-brca1-and-brca2-germline-mutations-in-female-breast-cancer-patients-using-next-generation-sequencing/349554.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this study on BRCA1 and BRCA2?","Question",{"text":63,"@type":64},"To investigate germline mutations in BRCA1 and BRCA2 among Egyptian female breast cancer patients using next-generation sequencing.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the samples collected and how many groups were included?",{"text":68,"@type":64},"Blood samples were sequenced from primary breast cancer patients (n=22), benign breast lesions (n=5), and healthy controls (n=7).",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings about genetic variations and their types?",{"text":72,"@type":64},"A total of 135 variations were detected: 59 in BRCA1 and 76 in BRCA2, including 2 indels and 133 SNVs, with missense variants making up about 55% and intronic changes comprising most BRCA1/BRCA2 variation counts.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349554,1790462203,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:06/29/2025 Acceptance:01/30/2026 Published:02/06/2026 |\n| --- | --- |\n\nIdentification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing  \nMenha Swellam1,2 *, Mohamed K. Khalifa3,4, Amira M Nageeb1,2, Magda Sayed Mahmoud1,2, Maha Hashim1,2, AliaaAlisslam I. A. Alshazly5, MagdyE. Mahfouz5, Lobna R Ez ElArab6, Madyha H. Mahmoud7, Mohamed Emam Sobeih8  \nAbstract  \nBackground: Breast cancer is the most common cancer affecting females according to WHO 2020 report, with BRCA1 and BRCA2 identified as the major tumor suppressor genes linked to disease susceptibility. Hence, the purpose of the current study was to investigate germline mutations among these genes in a group of Egyptian female breast cancer patients. Methods: Blood samples from primary breast cancer patients (n=22), benign breast lesions (n=5) and healthy controls (n=7) were sequenced for BRCA genes by next generation sequencer. Results: A total of 135 genetic variations were detected, 59 in BRCA1 and 76 BRCA2, 2 indels (insertion-deletion) and 133 SNV (single nucleotide variation), nearly 55% of those variants were missense variants, 38% were synonymous and 7% were nonsense. A total of 59 variations were detected in BRCA1 and they were categorized as exonic (n=10) and intronic (n=49) regions, BRCA1 exonic variants were categorized into: missense (n=12), non-coding transcript (n=11) synonymous (n=6), splice region synonymous (n=2), stop gain (n=2) and 3-prime UTR (n=1) variants. Regarding variations detected in BRCA2, 55 intronic and 21 exonic variants were identified. Among these 21 variants; 13 novel mutations and 8 formally reported as follows: 7 as benign and one previously reported with contradictory pathogenicity according to the Clinvar database which is a freely available, public archive of reports of the relationships between human variations and phenotypes hosted by the National Center for Biotechnology Information (NCBI) and funded by intramural National Institutes of Health (NIH) funding. Conclusion: BRCA1 and BRCA2 germline profiling based on next-generation sequencing technology among Egyptian breast cancer female patients revealed 135 germline variations-104 intronic and 31 exonic, respectively. Among the exonic variants; 13 were newly reported mutations. Hence further study is required to enhance mutational analysis which may benefit clinical system.  \nKeywords: Breast Cancer-BRCA genes-next generation sequencer-germ line profiling  \nAsian Pac J Cancer Prev, 27 (2), 575-581  \nIntroduction  \nWorldwide, breast cancer is the most common malignancy among women [1]. The National Malignancy Registry Program (NCRP) in Egypt’s most recent data indicates that breast cancer represents major prevalent cancer in women, accounting for 32.04% of all cancers [2] . Breast cancer susceptibility genes may be present in 5%–10% of instances of breast cancer, increasing the chance of malignancy [3]. A significant portion of breast cancer is caused by inherited predisposition [4] . BRCA1  \n(OMIM\\# 113705) and BRCA2 (OMIM\\# 600185) are two key genes linked to hereditary breast cancer and having a high chance of developing the disease, according to genetic linkage experts. In 1990 and 1995, these tumor suppressor genes were reported and recognized as breast cancer vulnerability genes. BRCA2 is found on chromosome 13q12–13, while BRCA1 is found on chromosome 17q21 [5, 6] . The functions of BRCA1 /2 are vital for normal cell function as they are included in the cellular DNA repair and inhibition of uncontrolled cell growth [7] . Germline mutations in these two highly  \n1Biochemistry Department, Biotechnology Research Institute, Giza, Egypt. 2High Throughput Molecular and Genetic laboratory, Central Laboratories Network and the Centers of Excellence, National Research Centre, Dokki, Giza, Egypt. 3CSO at Omicsense, Cairo, Egypt. 4Molecular pathology lab Children Cancer Hospita","cbCaikyZu9SZ2JmB","https://ap.wps.com/l/cbCaikyZu9SZ2JmB","pdf",366112,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## BRCA1 and BRCA2 role in hereditary breast cancer","[{\"question\":\"What is the purpose of this study on BRCA1 and BRCA2?\",\"answer\":\"To investigate germline mutations in BRCA1 and BRCA2 among Egyptian female breast cancer patients using next-generation sequencing.\"},{\"question\":\"How were the samples collected and how many groups were included?\",\"answer\":\"Blood samples were sequenced from primary breast cancer patients (n=22), benign breast lesions (n=5), and healthy controls (n=7).\"},{\"question\":\"What were the main findings about genetic variations and their types?\",\"answer\":\"A total of 135 variations were detected: 59 in BRCA1 and 76 in BRCA2, including 2 indels and 133 SNVs, with missense variants making up about 55% and intronic changes comprising most BRCA1/BRCA2 variation counts.\"}]","Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing | PDF",1790084303,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90d03659f8886df78f491a50efec3601.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a61a87e1221ac0ccb9e0af8ab572b8b0.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a170b3297b1b010d58572036103a40b.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1115493a3bc4c67591ca39212fa7dc16.webp",980,1385]